Biochemical evidence that patched is the Hedgehog receptor V Marigo, RA Davey, Y Zuo, JM Cunningham, CJ Tabin Nature 384 (6605), 176-179, 1996 | 1079 | 1996 |
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment Y Sakurai, AA Kolokoltsov, CC Chen, MW Tidwell, WE Bauta, ... Science 347 (6225), 995-998, 2015 | 587 | 2015 |
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes MF Saeed, AA Kolokoltsov, T Albrecht, RA Davey PLoS pathogens 6 (9), e1001110, 2010 | 493 | 2010 |
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus AS Kondratowicz, NJ Lennemann, PL Sinn, RA Davey, CL Hunt, ... Proceedings of the National Academy of Sciences 108 (20), 8426-8431, 2011 | 447 | 2011 |
Network medicine framework for identifying drug-repurposing opportunities for COVID-19 D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ... Proceedings of the National Academy of Sciences 118 (19), e2025581118, 2021 | 425 | 2021 |
Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry S Moller-Tank, AS Kondratowicz, RA Davey, PD Rennert, W Maury Journal of virology 87 (15), 8327-8341, 2013 | 288 | 2013 |
Evaluation of Ebola virus inhibitors for drug repurposing PB Madrid, RG Panchal, TK Warren, AC Shurtleff, AN Endsley, CE Green, ... ACS infectious diseases 1 (7), 317-326, 2015 | 273 | 2015 |
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents PB Madrid, S Chopra, ID Manger, L Gilfillan, TR Keepers, AC Shurtleff, ... PloS one 8 (4), e60579, 2013 | 271 | 2013 |
Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution D Fass, RA Davey, CA Hamson, PS Kim, JM Cunningham, JM Berger Science 277 (5332), 1662-1666, 1997 | 271 | 1997 |
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus MF Saeed, AA Kolokoltsov, AN Freiberg, MR Holbrook, RA Davey PLoS pathogens 4 (8), e1000141, 2008 | 229 | 2008 |
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus CL Hunt, AA Kolokoltsov, RA Davey, W Maury Journal of virology 85 (1), 334-347, 2011 | 191 | 2011 |
An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions DW Leung, D Borek, P Luthra, JM Binning, M Anantpadma, G Liu, ... Cell reports 11 (3), 376-389, 2015 | 162 | 2015 |
Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ... The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018 | 159 | 2018 |
Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection ME Miller, S Adhikary, AA Kolokoltsov, RA Davey Journal of virology 86 (14), 7473-7483, 2012 | 150 | 2012 |
Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus AA Kolokoltsov, D Deniger, EH Fleming, NJ Roberts Jr, JM Karpilow, ... Journal of virology 81 (14), 7786-7800, 2007 | 149 | 2007 |
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae JH Kuhn, Y Bao, S Bavari, S Becker, S Bradfute, JR Brister, AA Bukreyev, ... Archives of virology 158, 301-311, 2013 | 130 | 2013 |
Protein interaction mapping identifies RBBP6 as a negative regulator of Ebola virus replication J Batra, JF Hultquist, D Liu, O Shtanko, J Von Dollen, L Satkamp, ... Cell 175 (7), 1917-1930. e13, 2018 | 128 | 2018 |
Interferon-γ inhibits Ebola virus infection BA Rhein, LS Powers, K Rogers, M Anantpadma, BK Singh, Y Sakurai, ... PLoS pathogens 11 (11), e1005263, 2015 | 98 | 2015 |
Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection AL Barnett, RA Davey, JM Cunningham Proceedings of the National Academy of Sciences 98 (7), 4113-4118, 2001 | 98 | 2001 |
The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro T Lane, M Anantpadma, JS Freundlich, RA Davey, PB Madrid, S Ekins Pharmaceutical research 36, 1-6, 2019 | 97 | 2019 |